TGFB1 and neoplasm: MDSCs suppress the body’s adaptive immune response to tumor cells, inhibiting T cells and NKCs within the TIM by expressing arginase, inducible NOS, TGF-β, IL-10, and COX2, as well as by increasing the local Treg population, among others [70].